Aug. 17 at 9:10 PM
$BLGO
takeaway: The company has shown real resilience, while the subsidiaries are increasingly where the action—and potential value creation—lies.
• Clyra could be a major catalyst.
• CPG is now under BioLargo’s control, giving management more flexibility to build and monetize it.
• A meaningful water/PFAS or battery deal could be the event that materially changes the market’s view of BLGO.
• Minerals remains an upside wildcard—too early to call, but worth watching.
• Ultimately, the thesis is that execution at the subsidiary level will make the public-market valuation reflect the underlying value.